Eton Pharmaceuticals, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Sep 2017 | — | $-2.8M | $-2.8M |
| Mar 2018 | — | $-3.0M | $-3.0M |
| Jun 2018 | — | $-2.7M | $-3.1M |
| Sep 2018 | — | $-2.4M | $-2.9M |
| Dec 2018 | — | $-2.3M | $-3.7M |
| Mar 2019 | $500.0K | $-7.6M | $-7.4M |
| Jun 2019 | — | $-3.3M | $-3.2M |
| Sep 2019 | — | $-5.0M | $-5.0M |
| Dec 2019 | $459.0K | $-2.7M | $-2.7M |
| Mar 2020 | $99.0K | $-8.9M | $-9.0M |
| Jun 2020 | $20.0K | $-4.5M | $-4.7M |
| Sep 2020 | $-161.0K | $-6.3M | $-6.5M |
| Dec 2020 | $81.0K | $-7.4M | $-7.7M |
| Mar 2021 | $11.9M | $5.4M | $5.1M |
| Jun 2021 | $3.1M | $-2.3M | $-2.0M |
| Sep 2021 | $775.0K | $-5.8M | $-6.1M |
| Dec 2021 | $6.1M | $1.3M | $1.0M |
| Mar 2022 | $2.2M | $-5.1M | $-5.3M |
| Jun 2022 | $7.4M | $-1.3M | $-1.6M |
| Sep 2022 | $3.2M | $-2.9M | $-3.0M |
| Dec 2022 | $8.5M | $1.1M | $912.0K |
| Mar 2023 | $5.3M | $-2.5M | $-2.7M |
| Jun 2023 | $12.0M | $3.9M | $4.6M |
| Sep 2023 | $7.0M | $-548.0K | $-579.0K |
| Dec 2023 | $7.3M | $-2.0M | $-2.3M |
| Mar 2024 | $8.0M | $-800.0K | $-811.0K |
| Jun 2024 | $9.1M | $-2.9M | $-3.0M |
| Sep 2024 | $10.3M | $509.0K | $627.0K |
| Dec 2024 | $11.6M | $629.0K | $-598.0K |
| Mar 2025 | $17.3M | $-470.0K | $-1.6M |
| Jun 2025 | $18.9M | $-1.5M | $-2.6M |
| Sep 2025 | $22.5M | $-1.4M | $-1.9M |
| Dec 2025 | $21.3M | $2.5M | $1.5M |
| Mar 2026 | $24.3M | $2.4M | $1.6M |
| Jun 2026 | $37.6M | $12.8M | $11.6M |